பிராங்க்ஃபர்ட் ப்ரைம் தரநிலை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

QIAGEN N V : QIAGEN receives U S FDA emergency use authorization for rapid portable test that can analyze over 30 samples per hour for SARS-CoV-2 antigen

QIAGEN N V : QIAGEN receives U S FDA emergency use authorization for rapid portable test that can analyze over 30 samples per hour for SARS-CoV-2 antigen
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

John gilardiRobert reitzeThomas theuringerPhoebe lohJenny howardExchange commissionLife sciencesDrug administrationUs securities exchangeFrankfurt prime standardMolecular diagnosticsExchange actஃபோப் லோஜென்னி ஹோவர்ட்பரிமாற்றம் தரகுவாழ்க்கை அறிவியல்

QIAGEN N V : QIAGEN Reports Full Results for Q2 and H1 2021

QIAGEN N V : QIAGEN Reports Full Results for Q2 and H1 2021
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Thierry bernardJohn gilardiRobert reitzeThomas theuringerPhoebe lohExchange commissionHead of external communicationsCorporate communicationsLife sciencesUs securities exchangeFrankfurt prime standardChief executive officerChief financial officerMolecular diagnosticsExchange actAnnual report

QIAGEN Reports Full Results for Q2 and H1 2021

QIAGEN Reports Full Results for Q2 and H1 2021
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.

Thierry bernardJohn gilardiThomas theuringerExchange commissionHead of external communicationsCorporate communicationsLife sciencesUs securities exchangeFrankfurt prime standardChief executive officerChief financial officerMolecular diagnosticsExchange actAnnual reportPresident corporate communicationsBusiness wire

QIAGEN N : announces preliminary Q2 2021 results exceeding outlook, updates full-year 2021 outlook for declining COVID-19 test trends and plans new $100 million share repurchase program

QIAGEN N : announces preliminary Q2 2021 results exceeding outlook, updates full-year 2021 outlook for declining COVID-19 test trends and plans new $100 million share repurchase program
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomSouth koreaThierry bernardExchange commissionLife sciencesUs securities exchangeFrankfurt prime standardChief executive officerChief financial officerMiddle eastAnnual general meetingSafe harborInvestor relationsEuropean timeStandard time

QIAGEN N V : QIAGEN s NeuMoDx HAdV Quant Assay Secures CE-IVD Certification for Automated Testing to Detect Human Adenovirus Infections

QIAGEN N V : QIAGEN s NeuMoDx HAdV Quant Assay Secures CE-IVD Certification for Automated Testing to Detect Human Adenovirus Infections
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

John gilardiRobert reitzeNeumodx hadv quantThomas theuringerPhoebe lohExchange commissionEuropean unionLaboratory developed tests ldtsLife sciencesUs securities exchangeFrankfurt prime standardLaboratory developed testsHerpes simplex virusHuman herpesvirusChlamydia gonorrheaSentinel diagnostics